Home » Topics » Conferences

Conferences
RSS

Hematoprotective effects of PEG-rHuMGDF in mice

April 3, 1997

E-456, a minimum functional fragment of thrombomodulin from Asahi Chemical

April 3, 1997

New experimental data on Asahi Chemical's ART-123

April 3, 1997

Cationized AVP fragment for learning and memory disorders from Yakult

April 2, 1997

Sumitomo Metal characterizes new antiallergic/antiinflammatory agent

April 1, 1997

Nippon Shinyaku presents novel cerebroprotective agent

April 1, 1997

Novel 5-HT1A agonist described by Asahi Chemical

April 1, 1997

Kaken prepares broad-spectrum antiulcer agent

March 27, 1997

Antiplatelet 5-HT2A receptor antagonist characterized by Toa Eiyo

March 27, 1997

Novel antipsychotic agent reported by Asahi Chemical

March 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...